• Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sam Chun Dang Pharm Co Ltd

+ Add to Watchlist

000250:KS

8,240 KRW 160 1.90%

As of 02:13:03 ET on 09/15/2014.

Snapshot for Sam Chun Dang Pharm Co Ltd (000250)

Open: 8,470 Day's Range: 8,220 - 8,470 Volume: 132,578
Previous Close: 8,400 52wk Range: 3,725 - 10,900 1-Yr Rtn: +83.47%

Stock Chart for 000250

No chart data available.
  • 000250:KS 8,240
  • 1D
  • 1M
  • 1Y
8,400
Interactive 000250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 000250

Current P/E Ratio (ttm) 18.8991
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.1406
Earnings Per Share (ttm) 436.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 173,475.95
Shares Outstanding (M) 21.05
30 Day Average Volume 541,384
Price/Book (mrq) 1.7355
Price/Sale (ttm) 1.8626
Dividend Indicated Gross Yield 0.61%
Cash Dividend (KRW) 50.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth 0.00%
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 000250

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 000250

Sam Chun Dang Pharm Co., Ltd. (SCD) develops, manufactures, and markets medicines for human health care. The Company specializes in producing medical treatment drugs as well as diagnostic drugs. SCD Pharm's products include antibiotics, respiratory stimulants, pneumonia diagnosis devices, and many others.

Yun Dae-InChairman/Co-Rep DirectorKim Chang-HanVice Chairman
Park Jeon-KyoCo-Rep DirectorKim Dae-WookSenior Managing Director
More Company Profile & Key Executives for 000250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil